Canature Health Technology Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Canature Health Technology has a total shareholder equity of CN¥1.3B and total debt of CN¥967.1M, which brings its debt-to-equity ratio to 72.1%. Its total assets and total liabilities are CN¥3.0B and CN¥1.7B respectively. Canature Health Technology's EBIT is CN¥173.3M making its interest coverage ratio 15.8. It has cash and short-term investments of CN¥923.0M.
Wichtige Informationen
72.1%
Verhältnis von Schulden zu Eigenkapital
CN¥967.12m
Verschuldung
Zinsdeckungsgrad | 15.8x |
Bargeld | CN¥923.05m |
Eigenkapital | CN¥1.34b |
Gesamtverbindlichkeiten | CN¥1.69b |
Gesamtvermögen | CN¥3.03b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Canature Health Technology's (SZSE:300272) Soft Earnings Are Actually Better Than They Appear
Nov 04There's No Escaping Canature Health Technology Co., Ltd.'s (SZSE:300272) Muted Earnings Despite A 48% Share Price Rise
Oct 08We Like These Underlying Return On Capital Trends At Canature Health Technology (SZSE:300272)
Sep 30Canature Health Technology (SZSE:300272) Is Paying Out A Dividend Of CN¥0.10
May 27Market Might Still Lack Some Conviction On Canature Health Technology Co., Ltd. (SZSE:300272) Even After 28% Share Price Boost
May 08Canature Health Technology's (SZSE:300272) Earnings Offer More Than Meets The Eye
Apr 29Here's Why We Think Canature Health Technology (SZSE:300272) Is Well Worth Watching
Apr 01Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 300272's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥1.2B).
Langfristige Verbindlichkeiten: 300272's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥459.3M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 300272's net debt to equity ratio (3.3%) is considered satisfactory.
Schulden abbauen: 300272's debt to equity ratio has increased from 22.4% to 72.1% over the past 5 years.
Schuldendeckung: 300272's debt is well covered by operating cash flow (31%).
Zinsdeckung: 300272's interest payments on its debt are well covered by EBIT (15.8x coverage).